| Literature DB >> 10728173 |
V Ricca1, E Mannucci, A Paionni, M Di Bernardo, M Cellini, P L Cabras, C M Rotella.
Abstract
The efficacy of venlafaxine and fluoxetine in the treatment of atypical anorexia nervosa (AN) was compared in a controlled trial. A consecutive series of 24 atypical anorectic females was assigned to either venlafaxine (75 mg/day) or fluoxetine (40 mg/day) plus cognitive-behavioural therapy (CBT). Eating Disorder Examination (EDE12.0D), Beck Depression Inventory (BDI) and State and Trait Anxiety Inventory (STAI) scores were compared before and after 6 months of treatment. Venlafaxine and fluoxetine determined an increase of body mass index (BMI) and a significant reduction of EDE12.0D and BDI scores; venlafaxine alone reduced STAI scores. It would seem that venlafaxine is as effective as fluoxetine when combined with CBT in the treatment of atypical AN.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10728173 DOI： 10.1007/bf03341582
Source DB: PubMed Journal: Eat Weight Disord ISSN： 1124-4909 Impact factor: 4.652